Back to search

Article

Predicting antifolate resistance in the unculturable fungal pathogen <i>Pneumocystis jirovecii</i>

2025-05-08

Abstract excerpt

Pneumocystis jirovecii is a fungal pathogen causing Pneumocystis pneumonia in humans, mainly in immunocompromised individuals. Infections by P. jirovecii are treated using the antifolate combination drug trimethoprim-sulfamethoxazole (TMP-SMX), targeting the dihydrofolate reductase (DHFR) and the dihydropteroate synthase (DHPS). In recent years, there has been an increase of treatment failure, with no mutations o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c739f94d-d857-598f-8a0a-953cf6356720
DOI
10.1101/2025.05.07.652661
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting antifolate resistance in the unculturable fungal pathogen <i>Pneumocystis jirovecii</i>DOI 10.1101/2025.05.07.652661
Select a neighboring publication to make it the new centre.